Susceptibility to Macrolide and Beta-Lactam Antibiotics of Streptococcus pyogenes Strains Isolated over a Four-Year Period in Central Italy

REFERENCES

• Jackson MA, Burry VF, Olson LC. Multisystem group A beta-hemolytic streptococcal disease in children. Rev Infect Dis 1991; 13: 783–788.
   PubMedGoogle Scholar
• Strömberg A, Romanus V, Burman LG. Outbreak of group A streptococcal bacteremia in Sweden: an epidemiolog-ic and clinical study. J Infect Dis 1991; 164: 595–598.
   PubMed Web of Science ®Google Scholar
• Holm SE, Norrby A, Bergholm AM, Norgren M. Aspects of pathogenesis of serious group A streptococcal infections in Sweden, 1988-1989. J Infect Dis 1991; 166: 31–37.
   Web of Science ®Google Scholar
• Johnson DR, Stevens DL, Kaplan EL. Epidemiologic analysis of group A streptococcal serotypes associated with severe systemic infections, rheumatic fever, or uncomplicated pharyngitis. J Infect Dis 1992; 166: 374–382.
   PubMed Web of Science ®Google Scholar
• Stevens DL. Invasive group A streptococcus infections. Clin Infect Dis 1992; 14: 2–13.
   PubMed Web of Science ®Google Scholar
• Demers B, Simor AE, Vellend H, et al. Severe invasive group A streptococcal infections in Ontario, Canada: 1987-1991. Clin Infect Dis 1993; 16: 792–800.
   PubMed Web of Science ®Google Scholar
• Chelsom J, Halstensen A, Haga T, HOiby EA. Necrotising fasciitis due to group A streptococci in western Norway: incidence and clinical features. Lancet 1994; 344: 1111–1115.
   PubMed Web of Science ®Google Scholar
• Zackrisson G, Lind L, Roos K, Larsson P. Erythromycin-resistant beta-hemolytic streptococci group A in Goeteborg, Sweden. Scand J Infect Dis 1988; 20: 419–420.
   PubMed Web of Science ®Google Scholar
• Holmström L, Nyman B, Rosengren M, Wallander S, Ripa T. Outbreaks of infections with erythromycin-resistant group A streptococci in child day care centres. Scand J Infect Dis 1990; 22: 179–185.
   PubMed Web of Science ®Google Scholar
• Seppälä H, Nissinen A, Jarvinen H, et al. Resistance to erythromycin in group A streptococci. N Engl J Med 1992; 326: 292–297.
   PubMed Web of Science ®Google Scholar
• Trallero EP, Arenzana JMG, Egana MU. Erythromycin resistance in streptococci. Lancet 1989; ii:444–445.
   Google Scholar
• Phillips G, Parratt D, Orange GV, Harper I, McEwan H, Young N. Erythromycin-resistant Streptococcus pyo genes. J Antimicrob Chemother 1990; 25: 723–724.
   PubMed Web of Science ®Google Scholar
• Kim KS, Kaplan EL. Association of penicillin tolerance with failure to eradicate group A streptococci from patients with pharyngitis. J Pediatr 1985; 107: 681–684.
   PubMed Web of Science ®Google Scholar
• Feldman S, Bisno AL, Lott L, Dodge R, Jackson RE. Efficacy of benzathine penicillin G in group A streptococcal pharyngitis: reevaluation. J Pediatr 1987; 110: 783–787.
   PubMed Web of Science ®Google Scholar
• Ruoff KL. Streptococcus . In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH eds. Manual of Clinical Microbiolgy 6th ed. Washington DC: American Society for Microbiology, 1995: 299–307.
   Google Scholar
• Woods GL, Washington JA. Antibacterial susceptibility tests - dilution and disk diffusion methods. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH eds. Manual of Clinical Microbiology 6th ed. Washington DC: American Society for Microbiology, 1995: 1327–1341.
   Google Scholar
• Borzani M, Varotto F, Garlaschi L, Conio F, Dell'Olio M, Careddu P. Clinical and microbiological evaluation of miocamycin activity against group A beta-hemolytic strepto-cocci in pediatric patients. Three years' incidence of ery-thromycin-resistant group A streptococci. J Chemother 1989; 1: 35–38.
   Google Scholar
• Young RA, Gonzales JP, Sorkin EM. Roxithromycin. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy. Drugs 1989; 37: 8–41.
   Google Scholar
• Hardy DJ, Guay DRP, Jones RN. Clarithromycin, a unique macrolide. A pharmacokinetic, microbiological and clinical overview. Diagn Microbiol Infect Dis 1992; 15: 39–53.
   PubMed Web of Science ®Google Scholar
• Peters DH, Friedel HA, McTavish D. Azithromycin: a review of its antimicrobial activity, pharmacokinetic proper-ties and clinical efficacy. Drugs 1992; 44: 750–799.
   PubMed Web of Science ®Google Scholar
• Mitsuhashi S, Inoue M, Saito K, Nakae M. Drug resis-tance in Streptococcus pyo genes strains isolated in Japan. In: Schlessinger D ed. Microbiology. Washington, DC: American Society for Microbiology, 1982: 151–154.
   Google Scholar
• Bass JW, Weisse ME, Plymyer MR, Murphy S, Eberly BJ. Decline of erythromycin resistance of group A beta-hemolytic streptococci in Japan. Arch Pediatr Adolesc Med 1994; 148: 67–71.
   PubMedGoogle Scholar
• Retsema J, Girard A, Schelkly W, et al. Spectrum and mode of action of azythromycin (CP-62, 993) a new 15-mem-bered-ring macrolide with improved potency against gram-negative organisms. Antimicrob Agents Chemother 1987; 31: 1939-1947.
   Google Scholar
• Neu HC. Clinical microbiology of azithromycin. Am J Med 1991; 91 (Suppl 3A):125-185.
   Google Scholar
• Yao JDC, Moellering RC Jr. Antibacterial agents. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH eds. Manual of Clinical Microbiology 6th ed. Washington DC: American Society for Microbiology, 1995: 1281–1307.
   Google Scholar
• Brogden RN, Ward A. Ceftriaxone: a reappraisal of its antibacterial activity and pharmacokinetic properties, and an update on its therapeutic use with particular reference to once-daily administrations. Drugs 1988; 35: 604–645.
   PubMed Web of Science ®Google Scholar
• Barr NVH, Lin C-C, Radwanski E et al. The pharmaco-kinetics of ceftibuten in humans. Diagn Microbiol Infect Dis 1991; 14: 93–100.
   PubMed Web of Science ®Google Scholar
• Kearns GL, Reed MD, Jacobs RF, Ardite M, Yogev RD, Blumer JL. Single-dose pharmacokinetics of ceftibuten (SCH 39720) in infants and children. Antimicrob Agents Chemother 1991; 35: 2078-2084.
   Google Scholar
• Jones RN, Barry AL. Antimicrobial activity, spectrum and recommendations for disk diffusion susceptibility testing of ceftibuten (7432-S; SCH 39720), a new orally administered cephalosporin. Antimicrob Agents Chemother 1988; 32: 1576-1582.
   Google Scholar
• Neu H. Oral beta-lactam antibiotics from 1960 to 1993. Infect Dis Clin Pract 1993; 6: 394–404.
   Google Scholar